Safety and Clinical Effectiveness of Peginterferon Beta-1A for Relapsing Multiple Sclerosis in the Real-World Setting: Interim Results from the Plegridy Observational Program.
Multiple Sclerosis and Related Disorders（2022）
Key words
Multiple sclerosis,Peginterferon beta-1a,Real-world data,Safety,Effectiveness
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined